| Application of Radiomics in Breast Cancer (NCT04483804) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2018-01-01 |
| Prospective Validation of 3D Dose Metrics as Selection Criteria for Adaptive Radiotherapy in Breast Cancer Patients (NCT03385031) | Maastricht Radiation Oncology | 2018-01-01 |
| SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry (NCT03452774) | Massive Bio, Inc. | 2018-01-01 |
| Trial to Compare the Efficacy and Safety of Pegfilgrastim Biosimilar in Subjects With High Risk Stage Breast Cancer Receiving Chemotherapy (NCT02768714) | Eurofarma Laboratorios S.A. | 2018-01-01 |
| Stereotactic Body Radiotherapy for Patients With Breast Cancer Oligometastasis (NCT03295916) | Juravinski Cancer Center | 2018-01-01 |
| 12 weekS Adjuvant dOcetaxel Plus trastuzumaB in Patients With Small, Node-negative, HER2-positive Breast cancER (SOBER) (NCT03367676) | Ruijin Hospital | 2017-12-30 |
| Physical Rehabilitation Evaluation and Optimal Physical Therapy (PRE-OPT) (NCT04225572) | Masonic Cancer Center, University of Minnesota | 2017-12-27 |
| Post Mastectomy Pain Syndrome After Preoperative Stellate Ganglion Block for Breast Cancer Surgeries (NCT04238377) | National Cancer Institute, Egypt | 2017-12-26 |
| Effect of Chan-Chuang Qigong With Breathing Meditation on Quality of Life in Patients With Breast Cancer (NCT05385146) | Ching-I Chang | 2017-12-25 |
| Breast Cancer Registry Platform (NCT03417115) | iOMEDICO AG | 2017-12-22 |
| Breast Cancer Study of Preoperative Pembrolizumab + Radiation (NCT03366844) | Stephen Shiao | 2017-12-22 |
| Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Treatment-Refractory Solid Tumor Malignancies (NCT03199586) | Novita Pharmaceuticals, Inc. | 2017-12-21 |
| Pre-operative Immunotherapy Combination Strategies in Breast Cancer (NCT03395899) | Queen Mary University of London | 2017-12-21 |
| Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBC (NCT03326674) | Odonate Therapeutics, Inc. | 2017-12-21 |
| Shorter Scalp Cooling Time in Paclitaxel (NCT03266185) | Leiden University Medical Center | 2017-12-20 |
| Risk and Clinical Benefit of Chemotherapy and Intensive Endocrine Therapy for Luminal B1 Early-stage Breast Cancer (NCT03373708) | Zhiyong Yu | 2017-12-20 |
| MR-guided RAdiotherapy to Breast With Dose Escalation to regionaL Lymph NodEs (NCT03405519) | Royal Marsden NHS Foundation Trust | 2017-12-18 |
| Pathological Fracture in Potentially Unstable Spinal Metastases of Breast Cancer (NCT03365973) | Ruijin Hospital | 2017-12-15 |
| Tissue Resistivity in Breast Cancer Patients (NCT03402997) | Ente Ospedaliero Cantonale, Bellinzona | 2017-12-15 |
| Ph II Study of Pembrolizumab & Eribulin in Patients With HR+/HER2- MBC Previously Treated With Anthracyclines & Taxanes (NCT03222856) | MedSIR | 2017-12-14 |
| Study of Program Interest "Bouge" to Improve the Daily Physical Activity in Processings Treatment of Non-metastatic Breast Cancer (NCT03674515) | University Hospital, Brest | 2017-12-14 |
| Decision Support for BRCA Testing in Ethnically Diverse Women (NCT03470402) | Columbia University | 2017-12-13 |
| Capecitabine 7/7 Schedule With Neratinib in Patients With Metastatic HER2-Positive Breast Cancer (NCT03377387) | Memorial Sloan Kettering Cancer Center | 2017-12-13 |
| CDK 4/6 Inhibitor, Ribociclib, With Adjuvant Endocrine Therapy for ER-positive Breast Cancer (NCT03285412) | Massachusetts General Hospital | 2017-12-12 |
| Transcranial Direct Current Stimulation (tDCS) to Improve Fatigue and Cognitive Function (NCT03487601) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2017-12-12 |
| Bridge: Proactive Psychiatry Consultation and Case Management for Patients With Cancer (NCT03360695) | Massachusetts General Hospital | 2017-12-11 |
| Development Of A Blood Test To Improve The Performance Of Breast Cancer Screening (NCT03372902) | Memorial Sloan Kettering Cancer Center | 2017-12-07 |
| Preoperative Accelerated Partial Breast Irradiation for Triple Negative Breast Cancer Using Proton Beam Scanning (NCT03340402) | Massachusetts General Hospital | 2017-12-07 |
| CIrCuLAting Dna ESr1 Gene Mutations Analysis (NCT03318263) | Institut de Cancérologie de Lorraine | 2017-12-07 |
| Genetics and Heart Health After Cancer Therapy (NCT03510689) | Abramson Cancer Center at Penn Medicine | 2017-12-05 |
| Study of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological Malignancies (NCT03422679) | Cellestia Biotech AG | 2017-12-05 |
| Promoting Activity in Cancer Survivors (NCT03060941) | University of Texas Southwestern Medical Center | 2017-12-04 |
| Erector Spinae Plane Block Versus Serratus Plane Block for Breast Surgery (NCT03538483) | Ataturk University | 2017-12-01 |
| PORTAL: Patient-reported Outcomes After Routine Treatment of Atypical Lesions (NCT03070236) | Dana-Farber Cancer Institute | 2017-12-01 |
| A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies (NCT03329950) | Celldex Therapeutics | 2017-12-01 |
| A Phase II Study of Nivolumab in Combination With Cabozantinib for Metastatic Triple-negative Breast Cancer (NCT03316586) | Dana-Farber Cancer Institute | 2017-11-30 |
| Preoperative Stereotactic Ablative Body Radiotherapy (SABR) for Early-Stage Breast Cancer (NCT03137693) | H. Lee Moffitt Cancer Center and Research Institute | 2017-11-29 |
| Letrozole Plus Low-Dose Metronomic Capecitabine Versus EC-T (Epirubicin/Cyclophosphamide Followed by Docetaxel) as Neoadjuvant Therapy for ER+/HER2-negative Breast Cancer (NCT03507465) | Guangdong Provincial People's Hospital | 2017-11-29 |
| Added Value of Contrast Enhanced Spectral Mammography, CESM. A Pilot Study. (NCT03402529) | Region Skane | 2017-11-28 |
| Tucatinib, Palbociclib and Letrozole in Metastatic Hormone Receptor Positive and HER2-positive Breast Cancer (NCT03054363) | University of Colorado, Denver | 2017-11-27 |
| Pathological Complete Response Rate in Locally Advanced Breast Cancer With FEC, EC-T, or TC as Neoadjuvant Chemotherapy (NCT03349177) | Zhiyong Yu | 2017-11-27 |
| A Study of GDC-9545 Alone or in Combination With Palbociclib and/or Luteinizing Hormone-Releasing Hormone (LHRH) Agonist in Locally Advanced or Metastatic Estrogen Receptor-Positive Breast Cancer (NCT03332797) | Genentech, Inc. | 2017-11-24 |
| Fasting-mimicking Diet in Patients Undergoing Active Cancer Treatment (NCT03595540) | University of Genova | 2017-11-22 |
| Positron Emission Tomography (PET) Imaging With Zirconium-89 (89Zr)-Trastuzumab for Prediction of HER2 Targeted Therapy Effectiveness (NCT03321045) | University of Alabama at Birmingham | 2017-11-21 |
| Study to Evaluate the Feasibility of 13-C Pyruvate Imaging in Breast Cancer Patients Receiving Neoadjuvant Chemotherapy (NCT03121989) | Sunnybrook Health Sciences Centre | 2017-11-21 |
| Cognitive Dysfunction and Breast Cancer Coping Strategies Impact on QOL (NCT03476226) | Wake Forest University Health Sciences | 2017-11-18 |
| Pilot Study Evaluating a Perioperative E-follow-up Protocol in Patients With Ambulatory Surgery for Breast Cancer (NCT03289286) | Institut Claudius Regaud | 2017-11-17 |
| Bupivacaine vs Placebo for Unilateral Mastectomy Surgical Site Post-operative Pain Control (NCT03351348) | Memorial Sloan Kettering Cancer Center | 2017-11-16 |
| Detecting Circulating Tumor Cells (CTCs) and Cell Free DNA (cfDNA) in Peripheral Blood of Breast Cancer (BC) Patients to Develop the Clinical Application for Early Detection and Diagnostics (NCT03511859) | CellMaxLife | 2017-11-16 |
| Oral STAT3 Inhibitor, TTI-101, in Patients With Advanced Cancers (NCT03195699) | Tvardi Therapeutics, Incorporated | 2017-11-15 |
| PBMT for the Prevention of CIPN (NCT03391271) | Hasselt University | 2017-11-13 |
| A Study of Debio 1347 Plus Fulvestrant in Patients With Metastatic Breast Cancer (NCT03344536) | Memorial Sloan Kettering Cancer Center | 2017-11-10 |
| Trial of Sacituzumab Govitecan in Participants With Refractory/Relapsed Metastatic Triple-Negative Breast Cancer (TNBC) (NCT02574455) | Gilead Sciences | 2017-11-07 |
| Neoadjuvant Carbo/Paclitaxel Followed by Doxorubicin/Cyclophosphamide in Breast Cancer (NCT03301350) | University of Wisconsin, Madison | 2017-11-07 |
| Healthy Lifestyles and Quality of Life in Women With Breast Cancer (NCT04379908) | Spanish Breast Cancer Research Group | 2017-11-07 |
| Effects of Bright Light on Co-occurring Cancer-related Symptoms in Breast Cancer Survivors (NCT03304587) | Michigan State University | 2017-11-06 |
| Fujifilm DBT Plus S-View Versus FFDM Alone in the Detection of Breast Cancer (NCT03491917) | Fujifilm Medical Systems USA, Inc. | 2017-11-03 |
| Genetic Risk Assessment for Cancer Education and Empowerment (GRACE) Project (NCT03326713) | Rutgers, The State University of New Jersey | 2017-11-02 |
| AssessinG Efficacy of Carboplatin and ATezOlizumab in Metastatic Lobular Breast Cancer (NCT03147040) | The Netherlands Cancer Institute | 2017-11-02 |
| London Investigation Into diElectric Scanning of Lesions (NCT03302819) | Royal Marsden NHS Foundation Trust | 2017-11-01 |
| Neratinib +/- Fulvestrant in HER2+, ER+ Metastatic Breast Cancer (NCT03289039) | Dana-Farber Cancer Institute | 2017-10-25 |
| Hypofractionated Radiation Therapy for Patients With Breast Cancer Receiving Regional Nodal Irradiation (NCT02958774) | University of Kansas Medical Center | 2017-10-23 |
| Brain Stimulation For Cancer Smokers (NCT03419741) | Medical University of South Carolina | 2017-10-21 |
| Study Evaluating Hemay022 in Combination With Endocrine Therapy In Subjects With ER Positive and HER2 Positive Advanced Breast Cancer (NCT03308201) | Tianjin Hemay Pharmaceutical Co., Ltd | 2017-10-16 |
| Comparing 5 and 15 Fractions for Whole Breast Irradiation After Breast Conserving Surgery (NCT03677427) | University Hospital, Ghent | 2017-10-16 |
| Assessment of the Impact of RNA Genomic Profile on Treatment Decision-making in HER2 Equivocal Breast Cancer Patients (NCT03197805) | Centre Jean Perrin | 2017-10-16 |
| IMpact of PRehabilitation in Oncology Via Exercise - Breast Cancer (NCT03498157) | Milton S. Hershey Medical Center | 2017-10-15 |
| Depression and Body Image Distress Following Mastectomy With Reconstruction (NCT03428399) | Massachusetts General Hospital | 2017-10-12 |
| SPY-X: A Study to Assess the Feasibility of Using SPY Alone for Sentinel Node Localization for Melanoma or Breast Cancer (NCT03294330) | Milton S. Hershey Medical Center | 2017-10-11 |
| Engineering Gut Microbiome to Target Breast Cancer (NCT03358511) | Mayo Clinic | 2017-10-11 |
| AZD5363 in Patients With Advanced Solid Tumors Harboring AKT Mutations (NCT03310541) | Memorial Sloan Kettering Cancer Center | 2017-10-11 |
| A Phase 1, Multi-Center, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Minnelide™ Capsules Given Alone or in Combination With Protein-Bound Paclitaxel in Patients With Advanced Solid Tumors (NCT03129139) | Minneamrita Therapeutics LLC | 2017-10-10 |
| Treatment After Progression of Fulvestrant Among Metastatic Breast Cancer Patients (NCT03541863) | Fudan University | 2017-10-10 |
| TACTIC - TAA Specific Cytotoxic T Lymphocytes in Patients With Breast Cancer (NCT03093350) | Baylor College of Medicine | 2017-10-10 |
| Pre-existing Factors, Early Detection and Early Treatment of Breast Cancer Related Lymphedema (NCT03210311) | Universitaire Ziekenhuizen KU Leuven | 2017-10-09 |
| A Non-interventional Study for Women With HR-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer to Evaluate the Real-world Effectiveness of Treatment Algorithms Beginning With Ribociclib + AI/FUL, or With Endocrine Therapy or Chemotherapy as First Line Treatment (NCT06311383) | Novartis Pharmaceuticals | 2017-10-09 |
| Adaptations to Breast Cancer and Exercise (NCT03314168) | João Henkin | 2017-10-07 |
| Circulating Tumor DNA After Neoadjuvant Chemotherapy (NCT03357120) | Institut Bergonié | 2017-10-06 |
| Neoadjuvant Chemo-endocrine Therapy and Immunotherapy for Pre-menopausal Luminal B Breast Cancer Patients (NCT04659551) | Istituto Oncologico Veneto IRCCS | 2017-10-05 |
| PROACT: Can we Prevent Chemotherapy-related Heart Damage in Patients With Breast Cancer and Lymphoma? (NCT03265574) | South Tees Hospitals NHS Foundation Trust | 2017-10-04 |
| Implementing Systematic Distress Screening in Breast Cancer (NCT02941614) | Kaiser Permanente | 2017-10-02 |
| Post Mastectomy Hypofractionated Radiotherapy in High Risk Breast Cancer (NCT03319069) | Ahmed Ahm | 2017-10-01 |
| Radiotherapy After Mastectomy for Breast Cancer Patients at Increased Risk of Local Recurrence (NCT03101683) | Fondazione del Piemonte per l'Oncologia | 2017-10-01 |
| Pre-pectoral AlloDerm® to Reinforce Tissues in Tissue Expander Breast Reconstruction (NCT03195322) | Johns Hopkins University | 2017-10-01 |
| Couples-Based Mindfulness for Young Breast Cancer Survivors (NCT02840344) | University of Missouri-Columbia | 2017-10-01 |
| Implementing a Decision Aid for Breast Cancer and DCIS Patients Deciding on Their Radiation Treatment. (NCT03375801) | Maastricht University | 2017-10-01 |
| Assessment of Breast Cancer-Related Arm Lymphedema (NCT03978754) | Peking University People's Hospital | 2017-10-01 |
| Alternative Exercise Program to Improve Skeletal Muscle Function and Fatigue in Cancer Survivors (NCT02739620) | University of Vermont | 2017-10-01 |
| Role of Oncoplastic Breast Surgery In Breast Cancer Treatement (NCT03273348) | Assiut University | 2017-09-28 |
| Efficacy of Denosumab on Normal BMD in Women Receiving Adjuvant Aromatase Inhibitors for Early Breast Cancer (NCT03324932) | Kyoto Prefectural University of Medicine | 2017-09-25 |
| Focused Ultrasound and Pembrolizumab in Metastatic Breast Cancer (NCT03237572) | Patrick Dillon, MD | 2017-09-25 |
| Preoperative Fulvestrant With or Without Enzalutamide in ER+/Her2- Breast Cancer (NCT02955394) | University of Colorado, Denver | 2017-09-21 |
| Phase 1/2 Study of Amcenestrant (SAR439859) Single Agent and in Combination With Other Anti-cancer Therapies in Postmenopausal Women With Estrogen Receptor Positive Advanced Breast Cancer (NCT03284957) | Sanofi | 2017-09-20 |
| Care Coordination for Complex Cancer Survivors in an Integrated Safety Net System (NCT02943265) | University of Texas Southwestern Medical Center | 2017-09-18 |
| Yoga for Symptoms of Nerve Damage Caused by Chemotherapy (NCT03292328) | Memorial Sloan Kettering Cancer Center | 2017-09-18 |
| What Matters Most: Choosing the Right Breast Cancer Surgery for You (NCT03136367) | Dartmouth-Hitchcock Medical Center | 2017-09-18 |
| Evaluate The Accuracy Of Breast MRI Biopsy In Diagnosing A Complete Tumor Response For Some Women Following Neoadjuvant Chemotherapy For Breast Cancer (NCT03289195) | Memorial Sloan Kettering Cancer Center | 2017-09-18 |
| MEtronomic TrEatment Option in Advanced bReast cAncer (NCT02954055) | ETOP IBCSG Partners Foundation | 2017-09-13 |
| Intraoperative Radiation Therapy (IORT) in DCIS (NCT03216421) | Columbia University | 2017-09-12 |
| Survivorship Care Plans in a Community Oncology Practice (NCT03028584) | University of Wisconsin, Madison | 2017-09-11 |